The association of FTO genotype variants with lipid-related metabolic parameters has been documented, but mainly concerning overweight or obesity exposure, however, we must not discount that lean is also susceptible to lipid metabolic disorders [49], and we conducted the first analysis of the mutual interaction of FTO genotype variants with lean NAFLD and definite metabolic distinctions. Here, FTO is linked to metabolic dysfunction-associated steatotic liver disease.